Reversal of growth suppression by p107 via direct phosphorylation by cyclin D1/cyclin-dependent kinase 4

Molecular and Cellular Biology

Volumn 22, Issue 7, 2002, Pages 2242-2254

  Leng, Xiaohong ^a   Noble, Martin ^a   Adams, Peter D ^a   Qin, Jun ^a   Harper, J Wade ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ARGININE; BROXURIDINE; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; LEUCINE; LYSINE; PROTEIN P107; SERINE; THREONINE; TRANSCRIPTION FACTOR;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL CYCLE; ENZYME PHOSPHORYLATION; GROWTH INHIBITION; NONHUMAN; PEPTIDE MAPPING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; BINDING SITES; BLOTTING, WESTERN; CDC2-CDC28 KINASES; CELL DIVISION; CELL LINE; CYCLIN A; CYCLIN D1; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PEPTIDE FRAGMENTS; PEPTIDE MAPPING; PHOSPHORYLATION; PROTEIN CONFORMATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; RETINOBLASTOMA-LIKE PROTEIN P107; TRYPSIN;

ANIMALIA;

EID: 0036118561     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.7.2242-2254.2002     Document Type: Article

References (68)

1. Cyclin-dependent kinases
2. Identification of a cyclin-Cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors
3. Retinoblastoma protein contains a C-terminal motif that targets it for phosphorylation by cyclin-Cdk complexes
4. Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1
5. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins
6. The retinoblastoma protein pathway in cell cycle control and cancer
7. 1 cyclin complexes
8. Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kipl with cyclin A-Cdk2 and cyclin D2-Cdk4
9. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates
10. The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases
11. Requirements for cell cycle arrest by p16INK4a
12. Dual cyclin-binding domains are required for p107 to function as a kinase inhibitor
13. Cyclin-binding motifs are essential for the function of p21CIP1
14. The p21(Cip1) and p27(Kipl) CDK "inhibitors" are essential activators of cyclin D-dependent kinases in murine fibroblasts
15. Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation
16. 1 control causing immortalization and increased cell turnover under growth-restricting conditions
17. Multiple mechanisms regulate subcellular localization of human CDC6
18. Specific regulation of E2F family members by cyclin-dependent kinases
19. The regulation of E2F by pRB-family proteins
20. 1 control
21. 1 block
22. 1
23. The Rb/E2F pathway: Expanding roles and emerging paradigms
24. p107 and p130 associated cyclin A has altered substrate specificity
25. 1/S transition
26. A predictive scale for evaluating cyclin-dependent kinase substrates. A comparison of p34cdc2 and p33cdk2
27. Cyclin partners determine Pho85 protein kinase substrate specificity in vitro and in vivo: Control of glycogen biosynthesis by Pcl8 and Pcl10
28. pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes
29. Phosphorylation of E2F-1 by cyclin A-cdk2
30. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E·Cdk2
31. Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites
32. Negative regulation of the growth-promoting transcription factor E2F·1 by a stably bound cyclin A-dependent protein kinase
33. New functional activities for the p21 family of CDK inhibitors
34. Identification of a p130 domain mediating interactions with cyclin A/cdk 2 and cyclin E/cdk 2 complexes
35. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway
36. Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner
37. The retinoblastoma protein is phosphorylated on multiple sites by human cdc2
38. 1 cyclin-dependent kinases in the absence of retinoblastoma protein phosphorylation
39. The retinoblastoma gene family in differentiation and development
40. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16
41. Cyclin E-induced S phase without activation of the pRb/E2F pathway
42. Interaction between cyclin-dependent kinases and human papillomavirus replication-initiation protein E1 is required for efficient viral replication
43. Cell cycle-regulated phosphorylation of p220(NPAT) by cyclin E/Cdk2 in Cajal bodies promotes histone gene transcription
44. 1 cyclins
45. Growth suppression by p16ink4 requires functional retinoblastoma protein
46. 1 kinase activity for cdk6, a novel cyclin D partner
47. The A- and B-type cyclin-associated cdc2 kinases in Xenopus turn on and off at different times in the cell cycle
48. Cyclin-dependent kinases: Engines, clocks, and microprocessors
49. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis
50. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors
51. Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization
52. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex
53. 1 control and immortalization
54. p21CIP1 and Cdc25A: Competition between an inhibitor and an activator of cyclin-dependent kinases
55. Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A
56. 1 phase progression: Cycling on cue
57. 1-phase progression
58. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner
59. Use of an oriented peptide library to determine the optimal substrates of protein kinases
60. A bipartite substrate recognition motif for cyclin-dependent kinases
61. Mutational analysis of the Cy motif from p21 reveals sequence degeneracy and specificity for different cyclin-dependent kinases
62. p130 and p107 use a conserved domain to inhibit cellular cyclin-dependent kinase activity
63. 1 cyclin-associated kinases
64. 1/S cyclin-dependent kinases
65. Identification of phosphorylation sites in proteins separated by polyacrylamide gel electrophoresis
66. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein
67. p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F
68. The pRB-related protein p107 contains two growth suppression domains: Independent interactions with E2F and cyclin/cdk complexes